On 22 August, Gleneagles JPMC made history by performing its first-ever procedure using the world’s smallest heart pump.
The revolutionary Impella device supports patients with severe heart conditions, ensuring their hearts continue to beat during complex procedures.
Led by our expert cardiologists Dr Billal Patel, Dr Rajinikanth Rajagopal, and Dr Muhd Ezam Emran, the successful procedure marks a significant advancement in cardiac care for Brunei.
Dr Patel, Head of Interventional Cardiology at Gleneagles JPMC, shared, “This patient had to undergo a complex cardiac procedure. In his case, the risks were high as the patient already had weak and damaged heart muscles. With the help of the Impella device, the patient’s heart function was supported throughout, and we were able to complete the cardiac procedure successfully. The Impella device gives the doctors confidence to perform complex cases such as this one.”
With the patient now on the road to recovery, this landmark procedure sets a promising precedent for the future of cardiovascular health in our region. We are excited about the potential this technology holds for improving patient outcomes and enhancing our cardiac care capabilities.
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Mount Elizabeth Hospitals Celebrate 97 Wins at Singapore Health Quality Service Awards 2026
